VSQM
MRNA icon

V-Square Quantitative Management’s Moderna MRNA Stock Holding History

V-Square Quantitative Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$457K Buy
6,532
+1,528
+31% +$79.1K 0.04% 353
2026
Q1 		$254K Sell
5,004
-4,994
-50% -$233K 0.03% 489
2025
Q4 		$295K Sell
9,998
-513
-5% -$13.9K 0.03% 441
2025
Q3 		$271K Buy
10,511
+390
+4% +$10.9K 0.05% 168
2025
Q2 		$279K Buy
10,121
+2,614
+35% +$68.8K 0.04% 433
2025
Q1 		$213K Sell
7,507
-290
-4% -$10.3K 0.03% 489
2024
Q4 		$324K Buy
7,797
+2,148
+38% +$103K 0.05% 398
2024
Q3 		$378K Buy
5,649
+2,838
+101% +$261K 0.06% 367
2024
Q2 		$334K Sell
2,811
-967
-26% -$122K 0.05% 342
2024
Q1 		$403K Buy
3,778
+1,280
+51% +$129K 0.06% 317
2023
Q4 		$248K Buy
2,498
+666
+36% +$56K 0.04% 349
2023
Q3 		$189K Buy
+1,832
New +$204K 0.08% 378

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

V-Square Quantitative Management's MRNA Position: Q2 2026 in Review

V-Square Quantitative Management increased its Moderna (MRNA) stake by 31% in Q2 2026, buying an estimated $79.1K and bringing the position to 6,532 shares worth $457K. The position accounts for 0.04% of the portfolio, ranked #353.

V-Square Quantitative Management first reported a position in MRNA in Q3 2023 and has held it in 12 quarters since. 782 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • V-Square Quantitative Management held 6,532 shares of Moderna worth $457K as of Q2 2026.
  • V-Square Quantitative Management bought 1,528 Moderna shares in Q2 2026, an estimated $79.1K.
  • Moderna made up 0.04% of V-Square Quantitative Management's portfolio in Q2 2026, its #353 holding.
  • V-Square Quantitative Management first reported a position in Moderna in Q3 2023 and has held it in 12 quarters since.
  • 782 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on V-Square Quantitative Management's 13F filing for Q2 2026, filed 27 Jul 2026.